HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edward F Jackson Selected Research

Hypertension (High Blood Pressure)

11/2011Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edward F Jackson Research Topics

Disease

14Neoplasms (Cancer)
05/2019 - 02/2003
3Breast Neoplasms (Breast Cancer)
05/2019 - 11/2004
3Necrosis
04/2011 - 02/2003
3Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2009 - 07/2005
2Glioma (Gliomas)
07/2011 - 04/2008
2Glioblastoma (Glioblastoma Multiforme)
07/2011 - 04/2008
2Brain Neoplasms (Brain Tumor)
07/2011 - 04/2011
1Fatigue
11/2014
1Hypoxia (Hypoxemia)
11/2014
1Thrombocytopenia (Thrombopenia)
11/2014
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
06/2014
1Iron Overload
01/2012
1Proteinuria
11/2011
1Fallopian Tube Neoplasms
11/2011
1Carcinoma (Carcinomatosis)
11/2011
1Hypertension (High Blood Pressure)
11/2011
1Ovarian Neoplasms (Ovarian Cancer)
11/2011
1Neurologic Manifestations (Neurological Manifestations)
04/2011
1Head and Neck Neoplasms (Head and Neck Cancer)
04/2011
1Veterinary Venereal Tumors (Transmissible Venereal Tumor)
02/2003
1Residual Neoplasm
02/2003
1Learning Disabilities (Learning Disability)
04/2002
1Neurofibromatosis 1 (Neurofibromatosis Type I)
04/2002

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
01/2017 - 11/2004
5Contrast MediaIBA
01/2015 - 11/2004
3GadoliniumIBA
04/2011 - 02/2003
2Pharmaceutical PreparationsIBA
01/2017 - 11/2014
2Bevacizumab (Avastin)FDA Link
11/2014 - 04/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014 - 07/2011
2afliberceptIBA
11/2011 - 07/2011
2Gadolinium DTPA (Magnevist)FDA Link
10/2007 - 02/2003
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2014
1Bortezomib (Velcade)FDA Link
11/2014
1NicotineFDA Link
06/2014
1IronIBA
01/2012
1Docetaxel (Taxotere)FDA Link
11/2011
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2011
1Temozolomide (Temodar)FDA LinkGeneric
07/2011
1Endothelial Growth FactorsIBA
07/2011
1Proteins (Proteins, Gene)FDA Link
07/2011
1Irinotecan (Camptosar)FDA LinkGeneric
04/2008
1Thalidomide (Thalomid)FDA Link
04/2008
1EnzymesIBA
04/2008
1Angiogenesis InhibitorsIBA
04/2008
1Anticonvulsants (Antiepileptic Drugs)IBA
04/2008
1Fluorescein-5-isothiocyanate (FITC)IBA
10/2007
1LectinsIBA
10/2007
1gadomer 17IBA
10/2007
1Pentetic Acid (DTPA)FDA LinkGeneric
07/2007
1AcidsIBA
07/2007
1paclitaxel poliglumex (XYOTAX)IBA
07/2007
1orantinib (SU6668)IBA
11/2004
1Biological ProductsIBA
11/2004
1PolymersIBA
11/2004
1Temazepam (Nocturne)FDA LinkGeneric
04/2002

Therapy/Procedure

10Therapeutics
11/2014 - 02/2003
3Drug Therapy (Chemotherapy)
12/2013 - 07/2007
3Brachytherapy
12/2009 - 07/2005
2Aftercare (After-Treatment)
12/2013 - 11/2004
1Neoadjuvant Therapy
05/2019
1Radiotherapy
07/2007
1Intravenous Injections
11/2004
1Lasers (Laser)
02/2003